General discussion, page-3924

There are not too many ASX “Pot stocks” at all that will benefit from the USA opening their market up in my view. The big USA companies and some Canadians ones will be the ones to capitalise so most of SP pumps are BS in my view.
Where IHL and some others differ is with global IP for drugs in huge markets. Anyway most of us are aware of this but if our OSA trial is successful, I believe there will be huge interest from the USA and everywhere else. TBI huge too, and obviously 675a.